Teyi Pharmaceutical Group (002728.SZ) Earnings Analysis

Teyi Pharmaceutical Group (002728.SZ) has no confirmed upcoming earnings date. Trailing P/E 61.39.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does 002728.SZ next report earnings?

No confirmed upcoming earnings date is currently scheduled for 002728.SZ. This page updates as the calendar is published.

002728.SZ earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-03-230.0329 CNYn/an/an/a
2025-10-230.0545 CNYn/an/an/a
2025-04-250.06 CNYn/an/an/a
2024-10-250.00651 CNYn/an/an/a
2024-07-25-0.01267 CNYn/an/an/a

002728.SZ valuation and analyst view

Trailing P/E61.39
Trailing EPS0.14724 CNY
Price / book2.52
Dividend yield1.66%
Market cap4.42B

Limited or no published sell-side analyst coverage for this symbol.

Related research pages

Frequently asked questions

When is Teyi Pharmaceutical Group (002728.SZ)'s next earnings date?

No confirmed upcoming earnings date is currently scheduled for 002728.SZ. This page updates as the calendar is published.

Did 002728.SZ beat earnings last quarter?

Consensus estimate data was not available for 002728.SZ's 2026-03-23 report.

What is 002728.SZ's current P/E ratio and EPS?

002728.SZ trades at a trailing P/E of 61.39 on trailing EPS of 0.14723997640405634 CNY.

What do analysts rate 002728.SZ?

002728.SZ has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.